Jun Cao

1.2k total citations
48 papers, 823 citations indexed

About

Jun Cao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jun Cao has authored 48 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Jun Cao's work include RNA modifications and cancer (11 papers), RNA Research and Splicing (8 papers) and Cancer-related molecular mechanisms research (5 papers). Jun Cao is often cited by papers focused on RNA modifications and cancer (11 papers), RNA Research and Splicing (8 papers) and Cancer-related molecular mechanisms research (5 papers). Jun Cao collaborates with scholars based in China, United States and United Kingdom. Jun Cao's co-authors include Zhi‐Qiang Ling, Minghua Ge, Xiaoping Zou, Connor A. Emdin, Da‐Zhi Wang, Douglas B. Cowan, Thomas Callender, Kazem Rahimi, Wenjia Liu and Yulin Yao and has published in prestigious journals such as Blood, The Journal of Immunology and Circulation Research.

In The Last Decade

Jun Cao

47 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Cao China 17 385 136 131 122 103 48 823
Shilin Xia China 17 365 0.9× 133 1.0× 241 1.8× 193 1.6× 65 0.6× 47 820
Yong Lin China 17 338 0.9× 191 1.4× 84 0.6× 92 0.8× 56 0.5× 42 762
Mahta Mazaheri Iran 19 195 0.5× 122 0.9× 108 0.8× 122 1.0× 32 0.3× 65 735
Ningning Zhang China 16 305 0.8× 84 0.6× 107 0.8× 106 0.9× 112 1.1× 97 822
Pablo Letelier Chile 16 509 1.3× 336 2.5× 162 1.2× 133 1.1× 37 0.4× 33 921
Liang Shi China 14 257 0.7× 177 1.3× 139 1.1× 85 0.7× 30 0.3× 24 668
Miki Ito Japan 16 355 0.9× 60 0.4× 139 1.1× 229 1.9× 27 0.3× 57 861
Alok R. Khandelwal United States 16 191 0.5× 68 0.5× 81 0.6× 125 1.0× 58 0.6× 39 642
Jianhua Yu China 19 384 1.0× 217 1.6× 159 1.2× 135 1.1× 255 2.5× 93 937

Countries citing papers authored by Jun Cao

Since Specialization
Citations

This map shows the geographic impact of Jun Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Cao more than expected).

Fields of papers citing papers by Jun Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Cao. The network helps show where Jun Cao may publish in the future.

Co-authorship network of co-authors of Jun Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Cao. A scholar is included among the top collaborators of Jun Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Cao. Jun Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Jun, Ziyu Wei, Yu Nie, & Hou‐Zao Chen. (2024). Therapeutic potential of alternative splicing in cardiovascular diseases. EBioMedicine. 101. 104995–104995. 10 indexed citations
2.
Wang, Jian, Lin Ma, Huan Zeng, et al.. (2023). Distal radial access for neuroangiography and neurointerventions: systematic review and meta-analysis. BMC Neurology. 23(1). 405–405.
3.
Cao, Jun, Xin Wang, Vivek M. Advani, et al.. (2023). mt‐Ty 5'tiRNA regulates skeletal muscle cell proliferation and differentiation. Cell Proliferation. 56(8). e13416–e13416. 2 indexed citations
5.
Li, Jianping, Ziming Wang, Hecheng Li, et al.. (2022). Resveratrol inhibits TRAF6/PTCH/SMO signal and regulates prostate cancer progression. Cytotechnology. 74(5). 549–558. 9 indexed citations
6.
Cao, Jun, Andrew Routh, & Muge N. Kuyumcu‐Martinez. (2021). Nanopore sequencing reveals full‐length Tropomyosin 1 isoforms and their regulation by RNA‐binding proteins during rat heart development. Journal of Cellular and Molecular Medicine. 25(17). 8352–8362. 20 indexed citations
7.
Cao, Jun, Sunil K. Verma, Elizabeth Jaworski, et al.. (2021). RBFOX2 is critical for maintaining alternative polyadenylation patterns and mitochondrial health in rat myoblasts. Cell Reports. 37(5). 109910–109910. 21 indexed citations
8.
Zhang, Yi, et al.. (2020). Lidocaine inhibits the proliferation and invasion of hepatocellular carcinoma by downregulating USP14 induced PI3K/Akt pathway. Pathology - Research and Practice. 216(8). 152963–152963. 33 indexed citations
9.
Cao, Jun, Douglas B. Cowan, & Da‐Zhi Wang. (2020). tRNA-Derived Small RNAs and Their Potential Roles in Cardiac Hypertrophy. Frontiers in Pharmacology. 11. 572941–572941. 41 indexed citations
11.
Huang, Haili, Huijuan He, Yahong Wang, et al.. (2017). MiR-4673 Modulates Paclitaxel-Induced Oxidative Stress and Loss of Mitochondrial Membrane Potential by Targeting 8-Oxoguanine-DNA Glycosylase-1. Cellular Physiology and Biochemistry. 42(3). 889–900. 28 indexed citations
12.
Cao, Jun, Minghua Ge, & Zhi‐Qiang Ling. (2016). Fbxw7 Tumor Suppressor. Medicine. 95(7). e2496–e2496. 70 indexed citations
13.
Emdin, Connor A., Thomas Callender, Jun Cao, & Kazem Rahimi. (2015). Effect of antihypertensive agents on risk of atrial fibrillation: a meta-analysis of large-scale randomized trials. EP Europace. 17(5). 701–710. 30 indexed citations
14.
Yao, Weiqi, et al.. (2015). Human adipose-derived mesenchymal stem cells repair cisplatin-induced acute kidney injury through antiapoptotic pathways. Experimental and Therapeutic Medicine. 10(2). 468–476. 32 indexed citations
15.
Emdin, Connor A., Thomas Callender, Jun Cao, John J.V. McMurray, & Kazem Rahimi. (2015). Meta-Analysis of Large-Scale Randomized Trials to Determine the Effectiveness of Inhibition of the Renin-Angiotensin Aldosterone System in Heart Failure. The American Journal of Cardiology. 116(1). 155–161. 31 indexed citations
16.
Li, Jianping, Tie Chong, Ziming Wang, et al.. (2014). A novel anti-cancer effect of resveratrol: reversal of epithelial-mesenchymal transition in prostate cancer cells. Molecular Medicine Reports. 10(4). 1717–1724. 61 indexed citations
17.
Liu, Xia, et al.. (2014). [Hepatic perivascular epithelioid cell tumor: a clinicopathologic study].. PubMed. 43(8). 558–9. 1 indexed citations
18.
Cao, Jun, Lijiao Zhao, Shubin Jin, & Rugang Zhong. (2011). Relationship between the molecular structure and the anticancer activity of N‐(2‐chloroethyl)‐N′‐cyclohexyl‐N‐nitrosoureas: A theoretical investigation. International Journal of Quantum Chemistry. 112(3). 747–758. 4 indexed citations
19.
Zou, Xiaoping, et al.. (2008). Endoscopic Findings and Clinicopathologic Characteristics of Ischemic Colitis: A Report of 85 Cases. Digestive Diseases and Sciences. 54(9). 2009–2015. 71 indexed citations
20.
Cao, Jun. (2006). Effects of gastrin 17 on β-catenin/Tcf-4 pathway in Colo320WT colon cancer cells. World Journal of Gastroenterology. 12(46). 7482–7482. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026